• Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

    المصدر: Nasdaq GlobeNewswire / 08 أغسطس 2023 16:05:01   America/New_York

    N/A
شارك على،